EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Landscape of TPMT and NUDT15 Pharmacogenetic Variation in a Cohort of Canadian Pediatric Inflammatory Bowel Disease Patients

April M Kennedy, Anne M Griffiths iD, Aleixo M Muise, Thomas D Walters iD, Amanda Ricciuto, Hien Q Huynh iD, Eytan Wine iD, Kevan Jacobson iD, Sally Lawrence, Nicholas Carman, David R Mack, Jennifer C deBruyn und 15 weitere

Inflammatory Bowel Diseases · 2024

DOI: 10.1093/ibd/izae109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2024. Verfasst von April M Kennedy und 26 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Pyrophosphatases, Methyltransferases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institute of Health Research (CIHR), Children's Intestinal and Liver Disease (CH.I.L.D.), The Hospital for Sick Children Inflammatory Bowel Disease Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with inflammatory bowel disease (IBD) exhibit considerable interindividual variability in medication response, highlighting the need for precision medicine approaches to optimize and tailor treatment. Pharmacogenetics (PGx) offers the ability to individualize dosing by examining genetic factors underlying the metabolism of medications such as thiopurines. Pharmacogenetic testing can identify individuals who may be at risk for thiopurine dose-dependent adverse reactions including myelosuppression. We aimed to evaluate PGx variation in genes supported by clinical guidelines that inform dosing of thiopurines and characterize differences in the distribution of actionable PGx variation among diverse ancestral groups.

Methods

Pharmacogenetic variation in TPMT and NUDT15 was captured by genome-wide genotyping of 1083 pediatric IBD patients from a diverse Canadian cohort. Genetic ancestry was inferred using principal component analysis. The proportion of PGx variation and associated metabolizer status phenotypes was compared across 5 genetic ancestral groups within the cohort (Admixed American, African, East Asian, European, and South Asian) and to prior global estimates from corresponding populations.

Results

Collectively, 11% of the cohort was categorized as intermediate or poor metabolizers of thiopurines, which would warrant a significant dose reduction or selection of alternate therapy. Clinically actionable variation in TPMT was more prevalent in participants of European and Admixed American/Latino ancestry (8.7% and 7.5%, respectively), whereas variation in NUDT15 was more prevalent in participants of East Asian and Admixed American/Latino ancestry (16% and 15% respectively).

Conclusions

These findings demonstrate the considerable interpopulation variability in PGx variation underlying thiopurine metabolism, which should be factored into testing diverse patient populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrophosphatasesMethyltransferasesHumansFemaleCanadaMaleChildAdolescentAzathioprineInflammatory Bowel DiseasesMercaptopurinePharmacogenomic VariantsPharmacogeneticsCohort StudiesCrohn DiseaseGenotypeChild, PreschoolImmunosuppressive AgentsColitis, UlcerativePharmacogenomic TestingNudix Hydrolases

Stichwörter der Autor:innen

NUDT15TPMTgenetic ancestrypharmacogeneticsthiopurines

Substanzen

NUDT15 protein, humanPyrophosphatasesTPMT protein, humanMethyltransferasesAzathioprineMercaptopurineImmunosuppressive Agentsthiopurine methyltransferaseNudix Hydrolases

Autor:innen und Institutionen

  • Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • SickKids IBD Centre, Division of Gastroenterology, Hepatology & Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Child Health Evaluative Sciences, SickKids Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada.
  • Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
  • Cell Biology Program, SickKids Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.

ORCID-Profile: Anne M Griffiths, Thomas D Walters, Hien Q Huynh, Eytan Wine, Kevan Jacobson, Eileen Crowley, Talin Haritunians, Iris Cohn

Förderung

  • Canadian Institute of Health Research (CIHR)
  • Children's Intestinal and Liver Disease (CH.I.L.D.)
  • The Hospital for Sick Children Inflammatory Bowel Disease Center
  • Hemsley Charitable Trust
  • NIDDK NIH HHS
  • Children’s Intestinal and Liver Disease

Zitieren

APA

Kennedy, A. M., Griffiths, A. M., Muise, A. M., Walters, T. D., Ricciuto, A., Huynh, H. Q., Wine, E., Jacobson, K., Lawrence, S., Carman, N., Mack, D. R., deBruyn, J. C., Otley, A. R., Deslandres, C., El-Matary, W., Zachos, M., Benchimol, E. I., Critch, J., Schneider, R., …, & Cohn, I. (2024). Landscape of TPMT and NUDT15 Pharmacogenetic Variation in a Cohort of Canadian Pediatric Inflammatory Bowel Disease Patients. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izae109

Vancouver

Kennedy AM, Griffiths AM, Muise AM, Walters TD, Ricciuto A, Huynh HQ, et al. Landscape of TPMT and NUDT15 Pharmacogenetic Variation in a Cohort of Canadian Pediatric Inflammatory Bowel Disease Patients. Inflammatory Bowel Diseases. 2024. doi:10.1093/ibd/izae109

BibTeX
@article{Kennedy2024,
  author = {Kennedy, April M and Griffiths, Anne M and Muise, Aleixo M and Walters, Thomas D and Ricciuto, Amanda and Huynh, Hien Q and Wine, Eytan and Jacobson, Kevan and Lawrence, Sally and Carman, Nicholas and Mack, David R and deBruyn, Jennifer C and Otley, Anthony R and Deslandres, Colette and El-Matary, Wael and Zachos, Mary and Benchimol, Eric I and Critch, Jeffrey and Schneider, Rilla and Crowley, Eileen and Li, Michael and Warner, Neil and McGovern, Dermot P B and Li, Dalin and Haritunians, Talin and Rudin, Sarah and Cohn, Iris},
  title = {Landscape of TPMT and NUDT15 Pharmacogenetic Variation in a Cohort of Canadian Pediatric Inflammatory Bowel Disease Patients},
  journal = {Inflammatory Bowel Diseases},
  year = {2024},
  doi = {10.1093/ibd/izae109}
}
Kostenlos starten →